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Abstract 
Although clinical practice guidelines (CPGs) provide recommendations for how best to treat a typical patient with a given 
condition, patients and their representatives are not always engaged in CPG development. Despite the agreement that patient 
participation may improve the quality and utility of CPGs, there is no systematic, scalable method for engaging patients and 
their representatives, as well as no consensus on what exactly patients and their representatives should be asked to do during 
CPG development. To address these gaps, an interdisciplinary team of researchers, patient representatives, and clinicians 
developed the RAND/PPMD Patient-Centeredness Method (RPM) - a novel online approach to engaging patients and their 
representatives in CPG development. The RPM is an iterative approach that allows patients and their representatives to 
provide input by (1) generating ideas; (2) rating draft recommendations on two criteria (importance and acceptability); (3) 
explaining and discussing their ratings with other participants using online, asynchronous, anonymous, moderated 
discussion boards, and (4) revising their responses if needed. The RPM was designed to be consistent with the 
RAND/UCLA Appropriateness Method used by clinicians and researchers to develop CPG, while helping patients and their 
representative rate outcome importance and recommendation acceptability - two key components of the GRADE Evidence 
to Decision (EtD) framework. With slight modifications, the RPM has the potential to explore consensus among key 
stakeholders on other dimensions of the EtD, including feasibility, equity, and resource use. 
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Clinical practice guidelines (CPGs) provide 
recommendations for how best to treat a typical patient 
with a given condition [1] and therefore play an important 
role in ensuring the delivery of high quality healthcare to 
patients [2,3]. The process of CPG development, however, 
does not always include patients or their representatives 
[4]. Failure to recognize the needs and preferences of 
individuals with expertise in the “lived experience” of a 
given medical condition can negatively affect guideline 
quality, usefulness, legitimacy, and adherence. Conversely, 
patient inclusion in CPG development can help ensure that 





guidelines focus on topics, and outcomes important to 
patients, comprehensively identify risks and benefits of 
different recommendations, and address the feasibility and 
acceptability of care recommendations [5,6]. Research 
shows that patients and clinicians view the risk-benefit 
trade-off differently and patients and their families provide 
unique perspectives that may differ from factors that 
clinicians are trained to take into account [7,8]. Engaging 
all stakeholders with a legitimate interest in guideline 
development helps ensure that guidelines are created in a 
transparent, democratic manner and are acceptable to 
relevant stakeholder groups [9].  
Patients and their representatives can be involved at 
different stages of the process [10], ranging from topic 
selection and reviewing and grading the strength of 
evidence to developing recommendations [11]. They can 
also be asked their views on living with their condition, 
accessing services, perceived benefits and harms of 
treatment options, or clinical outcomes of importance 
[12,13]. Asking patients to join the evidence review group 
or to submit evidence that would be considered for 
guideline development [12] could broaden the range of 
evidence that the guideline developers consider. Engaging 
patients in reviewing existing studies on patient 
preferences and soliciting input in designing data 
collection instruments can help identify areas where 
patients and caregivers feel guideline recommendations are 
most needed [14].  
But with some exceptions, involving patients in GDGs 
typically means including only a few patient 
representatives rather than proactively engaging a wider 
group of patients, as budgetary and logistical constraints 
typically make broad outreach infeasible [15,16]. There is 
no consensus about how patients should participate in CPG 
development - for example, should they be active members 
of guideline groups, or should patient input and 
preferences be shared only with clinicians in guideline 
groups [17]? Moreover, there is little clarity about how 
guidelines should reflect patient-based evidence, or 
information generated by patients about different aspects 
of care, patient preferences, and care experiences [18,19].  
Despite the realization that broad patient participation 
may improve the quality and utility of CPGs [20], there is 
no systematic, scalable method for engaging patients and 
no agreement on what exactly patients and their 
representatives should be asked to do during guideline 
development. Research is needed to develop and evaluate a 
scalable, non-burdensome, and culturally appropriate way 
to involve patients and their caregivers in developing 
CPGs. The method should be consistent with the approach 
clinicians use to develop consensus or evidence-based 
CPGs and useful for soliciting input from even hard-to-
engage patient populations.  
To address this challenge, a team of researchers from 
RAND and clinicians, caregivers, and patients from the 
Parent Project Muscular Dystrophy (PPMD) developed the 
RAND/PPMD Patient-Centeredness Method (RPM) and 
tested it using recently revised Duchenne Muscular 
Dystrophy (DMD) care considerations [21-23], or care 
guidelines, as they are commonly called in the Duchenne 
community. Clinical experts on DMD used a consensus-
development method known as the RAND/UCLA 
Appropriateness Method (RAM) or modified-Delphi 
method [1], which involves reviewing existing evidence, 
rating the clinical appropriateness and necessity of 
different assessment and treatment options, discussing the 
rating results, and revising the original ratings if needed. 
The revised set of care considerations covers 11 domains 
of care. However, patients and caregivers were consulted 
in developing recommendations for only one domain. The 
lack of patient and caregiver participation in developing 
the 2018 DMD care considerations offered an opportunity 
to develop and test a new method for involving a large 
group of patients and caregivers in CPG development. We 
did so by engaging individuals with DMD and their 
caregivers; experts on guideline development, RAM, and 
DMD; as well as clinicians and genetic counselors working 
with Duchenne families [24].  
 
 
Patient-centeredness of guideline 
recommendations 
 
While clinicians and researchers have the most expertise in 
identifying clinically appropriate and necessary treatments, 
patients and caregivers are best positioned to judge the 
extent to which the guideline recommendations are patient-
centered. According to the Institute of Medicine (IOM), 
patient-centered care is defined as “care that is respectful 
of, and responsive to, individual patient preferences, needs 
and values, and ensuring that patient values guide all 
clinical decisions” [25]. When asked about what makes 
care patient-centered, our study participants agreed with 
this definition and stated that patient-centered care is 
evidence-based care provided by clinicians who listen to, 
understand, and account for patients’ care needs, 
preferences, and values. They also felt that patient-centered 
care is team-based and requires inclusion of patients and 
caregivers as active decision-makers who work together 
with doctors on developing care plans. “Healthcare is 
patient-centered when educated patients and family present 
ideas, concerns, and beliefs to the practitioner, and the 
whole team comes together to create a plan of care”, said 
one caregiver.  
From the perspective of clinicians, researchers, and 
guideline developers we interviewed, patients and 
caregivers can help ensure patient-centeredness of 
guideline recommendations in three ways. First, their input 
can help guideline developers determine what care 
outcomes should be considered, whether the outcomes 
included in the guidelines are important to patients, and 
whether the selected outcomes are likely to positively 
impact their quality of life. Because clinicians may not 
necessarily think about quality of life issues during the 
guideline development process, including patients can help 
make guidelines more relevant to their needs and 
preferences. Second, patients and caregivers can help 
clinicians and guideline developers better understand 
emotional and physical burdens related to getting care. 
Some treatment options may be psychologically taxing, 
while others physically challenging. For example, patients  
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Figure 1 The RAND/PPMD Patient-Centeredness Method (RPM)  
 
 
taking glucocorticoids to delay loss of ambulation, 
preserve upper body function, and/or  delay  or  prevent 
scoliosis, have to deal with such potential negative side 
effects of this treatment as weight gain, delayed puberty, 
short stature, bone loss and behavioral changes. Moreover, 
many bone health assessments, such as DEXA scans and 
X-rays, may be physically challenging to individuals with 
Duchenne because they require the ability to lay still. 
Finally, patients can provide important contextual 
information that can affect feasibility of, and likely 
adherence to, guideline recommendations. Patient and 
caregiver input can help ensure that the recommendations 
are realistic, focusing on such issues as convenience, 
accessibility, and costs. 
Taken together, these findings suggest that one of the 
most useful ways patients and caregivers could contribute 
to guideline development is by providing their input on 
two key components of patient-centered care: (1) the 
importance of the outcomes that a particular care 
recommendation is trying to achieve for a typical patient 
and (2) the acceptability of the process of following the 
recommendation for a typical patient. We consider the 
importance and acceptability to be the patient equivalent or 
analogous to the appropriateness and necessity that experts 






The RPM is a novel online modified-Delphi approach to 
patient engagement in CPG development that allows 
patients and their representatives to provide input on the 
patient-centeredness of draft guideline recommendations 
by participating in an optional idea generational round, 
two rating rounds, and an online discussion round. Ideally, 
patient and caregiver input should be solicited before the 
guidelines are finalized to ensure that recommendations are 
based on the systematic review of existing evidence and 
clinical expertise and are consistent with patients’ care 
preferences and needs.  
The RPM is based on the Delphi method [26], the 
RAM [1], and the GRADE Evidence to Decision 
Framework (EtD) [6,27]. The RPM borrows 3 main 
features from the Delphi method: an iterative approach to 
data collection, participant anonymity, and controlled 
feedback on how each participant’s own responses 
compare to those of the group. The RPM borrows 3 main 
features from RAM: 9-point rating scales, the RAM 
approach to measuring consensus, and direct interaction 
among participants. Finally, the RPM adapts its 
operationalization of patient-centeredness from the 
GRADE EtD: namely the importance and acceptability of 
guideline recommendations as key areas for which patients 
have the most expertise.  
Designed to solicit input from large and diverse groups, 
the RPM is best implemented online to ensure convenience 
and efficiency of data collection and analysis. An online 
data collection platform with survey, automated data 
analysis, and discussion functionalities, such as 
ExpertLens™ [28], is needed for the RPM implementation.  
The RPM requires iterative data collection. Patients and 
caregivers provide their input by generating ideas, rating 
and commenting on draft recommendations, discussing 
preliminary rating results, and revising their responses 
based on the panel’s preliminary ratings and group 
discussions. The RPM consists of the following 3-4 rounds 
(Figure 1). 
In an optional Round 0, patients and caregivers answer 
a series of open-ended and close-ended questions and 
engage in an online discussion about reasons for, barriers 
to and facilitators of seeking care for a given medical 
problem. This round helps generate information about care 
preferences, needs, and values that may not be available in 
the published literature. Once these data are summarized, 
the results are shared with panelists in subsequent rounds 
to help them rate patient-centeredness.   
In Round 1, participants rate and comment on draft 
recommendations already deemed clinically appropriate 
and necessary by experts. The recommendations should be 
presented in an easy-to-understand format and include a 
brief description of the clinical rationale, the process of 





following the recommendation, and any additional relevant 
information, such as treatment burden and side effects.   
Participants use 9-point Likert scales to rate patient-
centeredness of each recommendation, operationalized as 
the importance and acceptability. The end points of each 
scale are labeled as 1: not very important/acceptable and 9: 
very important/acceptable. Importance is defined as the 
extent to which a recommendation is likely to be consistent 
with the preferences, needs, and values of a typical patient 
with a given condition. Acceptability is defined as the 
extent to which the process of following a given 
recommendation is likely to be consistent with available 
resources (e.g., time and finances) and with the ethical 
standards of a typical patient with a given condition.  
To help participants comment about patients in general, 
it is important to provide them with a description of patient 
preferences and needs that is either based on the literature 
review or identified as part of Round 0. Such information 
may also include a description of common barriers and 
facilitators of seeking care for a given condition. 
In addition to providing numeric responses, participants 
should explain the rationales behind their ratings by 
identifying the factors that affected their perspectives on 
importance and acceptability of each recommendation the 
most. Therefore, each rating question should be followed 
by a text box where participants could type their rationale 
comments. 
In Round 2, participants review and discuss Round 1 
results. Participants review charts showing the distribution 
of group responses, their own response, and the group 
median response. Rating data are analyzed to determine the 
existence of group consensus using the analytic approach 
described in the RAND/UCLA Appropriateness Method 
User’s Manual [1]. To ensure that the results of these 
analyses are easy-to-understand, color-coding of group 
decisions and hover-overs are used to show if consensus 
has been reached and to provide explanations of different 
statistical terms.  
In addition, rationale comments are summarized 
thematically to explain how and why patients and 
caregivers rated a recommendation. To ensure consistency 
between the analysis of rating data and rationale 
comments, summarizing qualitative data by rating tertiles 
is helpful. To illustrate, the analysis of comments from 
participants who rated a given recommendation as 7, 8, or 
9 provides a summary of why a recommendation was 
deemed important or acceptable.  
Participants also discuss Round 1 results using 
asynchronous, (partially) anonymous, and moderated 
discussion boards with a threaded structure. Asynchronous 
nature of discussions makes participation more convenient 
to participants and facilitates engagement across time 
zones. Using alpha-numeric participant IDs (i.e., patient 01 
or caregiver 12) that reveal a participant’s stakeholder 
group and assign a unique number helps ensure participant 
anonymity, while allowing for easy identification of all 
comments made by a given participant. Discussions are 
moderated to promote exchange of ideas and clarification 
of rationale comments.  
In Round 3, participants are given an opportunity to 
review Round 2 discussion and modify their original 
answers if they wish to do so. The wording of 
recommendations or any text that accompanies them could 
be modified based on Round 2 results. Such changes 
should be clearly identified. Participants are encouraged to 
explain why their responses changed using open-text boxes 
displayed after each rating question. 
 
 
Discussion and Conclusions 
 
The RPM offers a unique opportunity for guideline 
developers to engage large and diverse groups of patients, 
caregivers, and other relevant stakeholders in the process 
of developing guideline recommendations by soliciting 
their input on the patient-centeredness of draft 
recommendations using an online, modified-Delphi 
process. Designed to be consistent with the way clinicians 
and researchers participate in guideline development, the 
RPM helps collect information on outcome importance and 
treatment acceptability from the perspectives of patients 
and caregivers, which are two components of the EtD 
framework [6,27]. With slight modifications in rating 
criteria and the extension of the pool of invited 
participants, the RPM can be used to explore the existence 
of consensus among key stakeholders on other dimensions 
of the EtD, such as feasibility, equity, and resource use. 
Our team evaluated participation experiences of the 
individuals with DMD and caregivers who helped us test 
the RPM. The results of satisfaction surveys and semi-
structured interviews that are reported elsewhere in this 
issue of the Journal [29] suggest that participants had good 
experiences with the RPM, “citing the convenience, 
anonymity, and asynchronous nature of online 
engagement”, commenting on the benefits of learning from 
the experiences of both patients and caregivers, and 
stressing the importance of “learning and community-
building” that took place throughout the iterative process. 
Participants felt that the engagement process was not 
burdensome and appreciated the opportunity to engage 
from the comfort of their home. 
Similarly, clinicians we engaged as part of developing 
the method thought that it would provide a useful approach 
for incorporating patient preferences and values before the 
guidelines are finalized and help educate clinicians on 
factors that might affect patient adherence to 
recommendations. Patient and caregiver input can draw 
attention to factors that may make them less likely to 
follow the recommendations and therefore encourage 
guideline developers and clinicians to think about 
implementation strategies to address concerns about 
patient-centeredness raised by the panelists [6]. 
Because of the novelty and the promise of scalable and 
convenient engagement, this method should be formally 
validated and tested in the context of other clinical 
conditions and compared to other ways of engaging 
patients in CPG development. Future research should also 
empirically identify the value added of patient engagement 
in CPG development to determine the extent to which it 
produces significantly better guidelines that have higher 
patient adherence and lead to better patient outcomes. 
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